Rifampicin Isoniazid and Ethambutol Tablet
Generic Name |
Rifampicin Isoniazid and Ethambutol |
---|---|
Strength |
150 mg + 75 mg + 300 mg, 450 mg + 300 mg + 800 mg |
Form |
Tablet |
Packaging |
1 X 6 tablet |
Therapeutic use |
Tuberculosis |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Rifampicin, Isoniazid, Pyrazinamide and Ethambutol Tablet | 150 mg + 75 mg + 400 mg + 275 mg, 450 mg + 300 mg + 750 mg + 800 mg | Tuberculosis | |
Rifampicin Isoniazid and Ethambutol Tablet | 150 mg + 75 mg + 300 mg, 450 mg + 300 mg + 800 mg | Tuberculosis | |
Rifampicin Capsule | 150 mg, 300 mg | Antibiotic, Bacterial Infections | |
Ethambutol Tablet | 200 mg, 400 mg, 600 mg, 800 mg, 1000 mg | Antibiotic |
Product Description For Rifampicin Isoniazid and Ethambutol Tablet
products details and uses
Rifampicin Isoniazid and Ethambutol Tablet Exporter India, Manufacturer and Global Supplier
Rifampicin, Isoniazid, and Ethambutol Tablet is a highly effective combination medication widely used in the treatment of tuberculosis (TB). As a leading Rifampicin Isoniazid and Ethambutol Tablet Exporter India, we provide top-quality pharmaceutical formulations manufactured under WHO-GMP certified facilities. Our products are trusted by hospitals, government health programs, distributors, and global clients for their safety, efficacy, and consistent supply.
Rifampicin Isoniazid and Ethambutol Tablet Exporter India combination tablet works by combining the antibacterial actions of Rifampicin, Isoniazid, and Ethambutol to effectively combat Mycobacterium tuberculosis, the bacteria responsible for TB. Regular use as prescribed helps prevent the progression of tuberculosis and reduces the risk of drug resistance.
Uses of Rifampicin Isoniazid and Ethambutol Tablet Exporter India
-
Treatment of pulmonary and extrapulmonary tuberculosis
-
Effective therapy for drug-sensitive and multi-drug resistant TB
-
Helps reduce bacterial growth and prevent the spread of infection
-
Part of combination therapy to enhance efficacy and reduce resistance
-
Supports overall recovery from tuberculosis infection
Precautions for Rifampicin, Isoniazid, and Ethambutol Tablet
-
Should be taken only under medical supervision and according to prescribed doses
-
Regular liver function tests are recommended as Rifampicin and Isoniazid may affect liver health
-
Avoid alcohol consumption during therapy
-
Patients with pre-existing liver disease, kidney issues, or a history of allergic reactions should consult a doctor
-
Pregnant and breastfeeding women should use this medication only under medical guidance
-
Inform your doctor about other medications to avoid interactions, especially anticoagulants and anti-retrovirals
Possible Side Effects
-
Mild nausea, vomiting, or stomach discomfort
-
Orange-red discoloration of urine, sweat, or tears (common with Rifampicin)
-
Dizziness, fatigue, or headache
-
Rare but serious effects include liver toxicity, severe allergic reactions, or vision problems from Ethambutol
-
Immediate medical attention is required if severe reactions occur
Why Choose Us as Your Rifampicin Isoniazid and Ethambutol Tablet Exporter India?
-
High-Quality Manufacturing: Produced in WHO-GMP certified facilities with stringent quality control
-
Global Supply: Reliable export to clients across Asia, Africa, the Middle East, Europe, and Latin America
-
Timely Delivery: Efficient logistics ensure safe and prompt delivery
-
Competitive Pricing: Affordable rates without compromising quality or safety
-
Regulatory Compliance: Fully compliant with international pharmaceutical standards
-
Customer-Focused Service: Dedicated support for orders, documentation, and after-sales service
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.